Connect with us

Health & Fitness

Did Unrecognized Cardiac Amyloidosis Hinder Recent HFpEF Trials?

Routinely screening for cardiac amyloid and excluding those patients might increase the chances of finding efficacious treatments for heart failure with preserved ejection fraction, researchers suggest. Medscape Medical News

Published

on

Did Unrecognized Cardiac Amyloidosis Hinder Recent HFpEF Trials?